Handelsavisen
prelaunch
Companies Healthcare 096760.KS
09
096760.KS KRX Pharmaceuticals

JW Holdings Corp

$3 965,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
274,3B KRW
P/E
EV / Rev
Div yield
5,02 %
Op margin
17,9 %
ROE
21,9 %
Net margin
6,0 %
Debt / equity
1,35
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

JW Holdings Corp is a pharmaceutical company that generates revenue primarily through the development, production, and sale of prescription drugs and related healthcare products.

Business. JW Holdings Corp (096760.KS) is a pharmaceutical company engaged in the research, development, and sale of pharmaceutical products. The firm is headquartered in South Korea and is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
ActivityPharmaceuticals & Medical Research
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
21,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 096760.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 096760.KS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    JW Holdings Corp (096760.KS) is a pharmaceutical company engaged in the research, development, and sale of pharmaceutical products. The firm is headquartered in South Korea and is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    ActivityPharmaceuticals & Medical Research
    AI synthesis
    GENERATED

    JW Holdings Corp maintains a capital structure with a debt-to-equity ratio of 1.35, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.88, suggesting that it may face challenges in meeting short-term obligations without additional cash inflows. The company's price-to-book ratio of 0.99 and price-to-tangible-book ratio of 0.99 indicate that the market values the company's equity at nearly par with its tangible book value.

    In terms of profitability, JW Holdings Corp reports a return on equity (ROE) of 21.92%, which is a strong indicator of efficient use of shareholders' equity to generate profits. The return on assets (ROA) of 4.75% suggests that the company is generating a moderate return on its total asset base. These metrics are in line with the industry's preferred metrics for profitability and returns, though specific comparisons to cohort medians are not available in the provided data.

    The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company's exposure is not disclosed in the provided data, but the lack of segmental or geographic diversification may pose a concentration risk.

    JW Holdings Corp's growth trajectory is supported by a strong operating cash flow of 163,666,846,620 KRW and a free cash flow of 85,884,841,090 KRW, indicating the company's ability to fund operations and potentially reinvest in growth. The capital expenditure of -54,697,574,770 KRW suggests that the company is not currently investing heavily in new capital assets, which may affect its long-term growth potential.

    The company's risk profile includes a medium liquidity risk, as indicated by the current ratio of 0.88 and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the provided data. The company's valuation adjustments do not indicate any material changes to its financial position.

    Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes, but the strong operating and free cash flows suggest a stable financial position. The company's financial health is supported by its ability to generate consistent cash flows, which may help it navigate potential market challenges.

    Key takeaways
    • JW Holdings Corp has a strong return on equity (21.92%) and a moderate return on assets (4.75%), indicating efficient use of equity and assets to generate profits.
    • The company's liquidity position is assessed as medium, with a current ratio of 0.88, suggesting potential challenges in meeting short-term obligations.
    • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 1.35, indicating a balanced approach to financing.
    • JW Holdings Corp generates strong operating and free cash flows, which support its financial stability and potential for reinvestment.
    • The company's risk profile includes a medium liquidity risk and a low dilution risk, with no significant dilution potential identified.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3 965,00
    Market cap
    $265.35B
    Enterprise value
    $553.14B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    3.4x
    P / B
    1.0x
    P / Tangible book
    1.0x
    Tangible book
    $266.96B
    Net cash
    -$287.79B
    Current ratio
    0.9
    Debt / equity
    1.4
    ROA
    4.8%
    ROE
    21.9%
    Cash conversion
    280.0%
    CapEx / revenue
    -5.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin17,9 %Above P75
    Net Margin6,0 %Above median
    ROE21,9 %Best in class
    Capex / Rev-5,6 %Below median
    D/E1,35Bottom quartile
    Cash Conv2,80Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • JW Holdings Corp Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    096760.KSCanonical
    KRX · KRW

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage